Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Antibodies and resistance to natural HIV infection.

Nabel GJ, Sullivan NJ.

N Engl J Med. 2000 Oct 26;343(17):1263-5. Review. No abstract available.

PMID:
11071680
2.

Humoral immunity to HIV, SIV, and SHIV.

Haigwood NL, Zolla-Pazner S.

AIDS. 1998;12 Suppl A:S121-32. Review. No abstract available.

PMID:
9632993
3.

Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies.

Ruprecht RM, Hofmann-Lehmann R, Smith-Franklin BA, Rasmussen RA, Liska V, Vlasak J, Xu W, Baba TW, Chenine AL, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Montefiori DC, McClure HM.

Transfus Clin Biol. 2001 Aug;8(4):350-8. Review.

PMID:
11642027
4.

HIV vaccines--where are we going?

Heilman CA, Baltimore D.

Nat Med. 1998 May;4(5 Suppl):532-4. Review. No abstract available.

PMID:
9585205
5.

Prospects for vaccine protection against HIV-1 infection and AIDS.

Letvin NL, Barouch DH, Montefiori DC.

Annu Rev Immunol. 2002;20:73-99. Epub 2001 Oct 4. Review.

PMID:
11861598
6.

CTL ontogeny and viral escape: implications for HIV-1 vaccine design.

Yang OO.

Trends Immunol. 2004 Mar;25(3):138-42. Review. No abstract available.

PMID:
15036041
7.

Primate models of AIDS vaccine development.

Lamb-Wharton RJ, Joag SV, Stephens EB, Narayan O.

AIDS. 1997;11 Suppl A:S121-6. Review. No abstract available.

PMID:
9451975
8.

Nonhuman primate models for HIV vaccine development.

Letvin NL.

Immunodefic Rev. 1992;3(3):247-60. Review.

PMID:
1510838
9.

Vaccines against human immunodeficiency virus--progress and prospects.

Letvin NL.

N Engl J Med. 1993 Nov 4;329(19):1400-5. Review. No abstract available.

PMID:
8413438
10.

Cytotoxic T-cell epitopes in HIV/SIV infection.

Venet A, Walker BD.

AIDS. 1993;7 Suppl 1:S117-26. Review. No abstract available.

PMID:
7689848
11.

Current situation in the development of a preventive HIV vaccine.

Alcamí J, Joseph Munné J, Muñoz-Fernández MA, Esteban M.

Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:5-24. Review. English, Spanish.

PMID:
16373000
12.

Role of neutralizing antibodies in HIV infection.

Haigwood NL, Stamatatos L.

AIDS. 2003;17 Suppl 4:S67-71. Review. No abstract available.

PMID:
15080182
13.

Towards an HIV-1 vaccine: lessons from studies in macaque models.

Hulskotte EG, Geretti AM, Osterhaus AD.

Vaccine. 1998 May-Jun;16(9-10):904-15. Review.

PMID:
9682336
14.

AIDS vaccine development in primate models.

Almond NM, Heeney JL.

AIDS. 1998;12 Suppl A:S133-40. Review. No abstract available.

PMID:
9632994
15.
16.

Mucosal immunity, HIV transmission, and AIDS.

Miller CJ, McGhee JR, Gardner MB.

Lab Invest. 1993 Feb;68(2):129-45. Review. No abstract available.

PMID:
8441249
17.

First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies.

Warren JT, Dolatshahi M.

J Med Primatol. 1993 Feb-May;22(2-3):203-35. Review. No abstract available.

PMID:
8411110
18.

Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model.

Barratt-Boyes SM, Brown KN, Melhem N, Soloff AC, Gleason SM.

Immunol Res. 2006;36(1-3):265-74. Review.

PMID:
17337787
19.

Are we detouring from a direct route to development of HIV vaccines?

Fultz PN.

Vaccine. 1991 Nov;9(11):783-7. Review.

PMID:
1759499
20.

Mucosal Vaccination for Prevention of HIV Infection and AIDS.

Aldovini A.

Curr HIV Res. 2016;14(3):247-59. Review.

PMID:
26957199

Supplemental Content

Support Center